| ChAdOx1nCov-19 provides minimal protection against mild-moderate COVID-19 infection from B | Where is the Oxford-AstraZeneca vaccine made? Callaway, Ewen; Mallapaty, Smriti 2021-03-25 |
|---|---|
| "Covid-19: The E484K mutation and the risks it poses" | Safety and efficacy of the ChAdOx1 nCoV-19 vaccine AZD1222 against SARS-CoV-2: an interim analysis of four randomized controlled trials in Brazil, South Africa, and the UK |
AZD1222 US Phase III trial met primary efficacy endpoint in preventing COVID-19 at interim analysis.
| 351 coronavirus variant in young South African adults | Coleman, Justine 10 June 2020 |
|---|---|
| This trains our immune system so when we encounter , we can mount a defense | Belluz, Julia 23 November 2020 |
| So they took an adenovirus that normally infects chimpanzees, and genetically altered it so it can no longer replicate or cause disease | Woo, Jenny Strasburg and Stu October 21, 2020 |
|---|---|
| Walsh, Nick; Shelley, Jo; Duwe, Eduardo; Bonnett, William 27 July 2020 | That way when we are infected with , we can mount an effective immune response against it |
Department of Health and Social Care.
30